Аннотация
Despite the considerable arsenal of drugs used to the treatment of intestinal infections, need for search for drugs capable of improving the patient's condition and advancing the process of their recovery remains an urgent. The article presents the results of use of topical intestinal antiseptic nifuroxazide (Enterofuryl) in treatment of infants with intestinal viral and bacterial infections. It is established that the inclusion of Enterofuryl in therapy of intestinal infections contributes to a more rapid improvement in general condition of patients, normalization of appetite, and reduction in the duration of fever, vomiting, intoxication, and diarrheal syndrome. This leads to decrease of length of hospital stay by 2.3 days compared with a group of children who received baseline therapy.
